ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Huntingtons Disease Therapeutics Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-20M16990
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Huntingtons Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
BUY CHAPTERS

Global Huntingtons Disease Therapeutics Market Research Report 2025

Code: QYRE-Auto-20M16990
Report
April 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AmpliPhi Biosciences Corp
Prana Biotechnology Limited
Teva Pharmaceutical Industries Ltd
Auspex Pharmaceuticals
SOM Biotech
GlaxoSmithKline PLC
ValeantPharmaceuticals International lnc.
Ceregene Inc.Lundbeck
Cortex Pharmaceuticals lnc.
VertexPharmaceuticals Incorporated
Siena Biotech

Huntingtons Disease Therapeutics Market

The global market for Huntingtons Disease Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Huntingtons Disease Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Huntingtons Disease Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Huntingtons Disease Therapeutics in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Huntingtons Disease Therapeutics include ValeantPharmaceuticals International lnc., Alnylam Pharmaceuticals Inc., AmpliPhi Biosciences Corp, Ceregene Inc.Lundbeck, Prana Biotechnology Limited, Teva Pharmaceutical Industries Ltd., Cortex Pharmaceuticals lnc., VertexPharmaceuticals Incorporated, Auspex Pharmaceuticals, SOM Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Huntingtons Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Huntingtons Disease Therapeutics.
The Huntingtons Disease Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Huntingtons Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Huntingtons Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Huntingtons Disease Therapeutics Market Report

Report Metric Details
Report Name Huntingtons Disease Therapeutics Market
Segment by Type
  • Psychotherapy
  • Medical Treatement
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ValeantPharmaceuticals International lnc., Alnylam Pharmaceuticals Inc., AmpliPhi Biosciences Corp, Ceregene Inc.Lundbeck, Prana Biotechnology Limited, Teva Pharmaceutical Industries Ltd., Cortex Pharmaceuticals lnc., VertexPharmaceuticals Incorporated, Auspex Pharmaceuticals, SOM Biotech, GlaxoSmithKline, Siena Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Huntingtons Disease Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Huntingtons Disease Therapeutics Market report?

Ans: The main players in the Huntingtons Disease Therapeutics Market are ValeantPharmaceuticals International lnc., Alnylam Pharmaceuticals Inc., AmpliPhi Biosciences Corp, Ceregene Inc.Lundbeck, Prana Biotechnology Limited, Teva Pharmaceutical Industries Ltd., Cortex Pharmaceuticals lnc., VertexPharmaceuticals Incorporated, Auspex Pharmaceuticals, SOM Biotech, GlaxoSmithKline, Siena Biotech

What are the Application segmentation covered in the Huntingtons Disease Therapeutics Market report?

Ans: The Applications covered in the Huntingtons Disease Therapeutics Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Huntingtons Disease Therapeutics Market report?

Ans: The Types covered in the Huntingtons Disease Therapeutics Market report are Psychotherapy, Medical Treatement, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Huntingtons Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Psychotherapy
1.2.3 Medical Treatement
1.2.4 Others
1.3 Market by Application
1.3.1 Global Huntingtons Disease Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Huntingtons Disease Therapeutics Market Perspective (2020-2031)
2.2 Global Huntingtons Disease Therapeutics Growth Trends by Region
2.2.1 Global Huntingtons Disease Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Huntingtons Disease Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Huntingtons Disease Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Huntingtons Disease Therapeutics Market Dynamics
2.3.1 Huntingtons Disease Therapeutics Industry Trends
2.3.2 Huntingtons Disease Therapeutics Market Drivers
2.3.3 Huntingtons Disease Therapeutics Market Challenges
2.3.4 Huntingtons Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Huntingtons Disease Therapeutics Players by Revenue
3.1.1 Global Top Huntingtons Disease Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Huntingtons Disease Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Huntingtons Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Huntingtons Disease Therapeutics Revenue
3.4 Global Huntingtons Disease Therapeutics Market Concentration Ratio
3.4.1 Global Huntingtons Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Huntingtons Disease Therapeutics Revenue in 2024
3.5 Global Key Players of Huntingtons Disease Therapeutics Head office and Area Served
3.6 Global Key Players of Huntingtons Disease Therapeutics, Product and Application
3.7 Global Key Players of Huntingtons Disease Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Huntingtons Disease Therapeutics Breakdown Data by Type
4.1 Global Huntingtons Disease Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Huntingtons Disease Therapeutics Forecasted Market Size by Type (2026-2031)
5 Huntingtons Disease Therapeutics Breakdown Data by Application
5.1 Global Huntingtons Disease Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Huntingtons Disease Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Huntingtons Disease Therapeutics Market Size (2020-2031)
6.2 North America Huntingtons Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Huntingtons Disease Therapeutics Market Size by Country (2020-2025)
6.4 North America Huntingtons Disease Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Huntingtons Disease Therapeutics Market Size (2020-2031)
7.2 Europe Huntingtons Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Huntingtons Disease Therapeutics Market Size by Country (2020-2025)
7.4 Europe Huntingtons Disease Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Huntingtons Disease Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Huntingtons Disease Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Huntingtons Disease Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Huntingtons Disease Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Huntingtons Disease Therapeutics Market Size (2020-2031)
9.2 Latin America Huntingtons Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Huntingtons Disease Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Huntingtons Disease Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Huntingtons Disease Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Huntingtons Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Huntingtons Disease Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Huntingtons Disease Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ValeantPharmaceuticals International lnc.
11.1.1 ValeantPharmaceuticals International lnc. Company Details
11.1.2 ValeantPharmaceuticals International lnc. Business Overview
11.1.3 ValeantPharmaceuticals International lnc. Huntingtons Disease Therapeutics Introduction
11.1.4 ValeantPharmaceuticals International lnc. Revenue in Huntingtons Disease Therapeutics Business (2020-2025)
11.1.5 ValeantPharmaceuticals International lnc. Recent Development
11.2 Alnylam Pharmaceuticals Inc.
11.2.1 Alnylam Pharmaceuticals Inc. Company Details
11.2.2 Alnylam Pharmaceuticals Inc. Business Overview
11.2.3 Alnylam Pharmaceuticals Inc. Huntingtons Disease Therapeutics Introduction
11.2.4 Alnylam Pharmaceuticals Inc. Revenue in Huntingtons Disease Therapeutics Business (2020-2025)
11.2.5 Alnylam Pharmaceuticals Inc. Recent Development
11.3 AmpliPhi Biosciences Corp
11.3.1 AmpliPhi Biosciences Corp Company Details
11.3.2 AmpliPhi Biosciences Corp Business Overview
11.3.3 AmpliPhi Biosciences Corp Huntingtons Disease Therapeutics Introduction
11.3.4 AmpliPhi Biosciences Corp Revenue in Huntingtons Disease Therapeutics Business (2020-2025)
11.3.5 AmpliPhi Biosciences Corp Recent Development
11.4 Ceregene Inc.Lundbeck
11.4.1 Ceregene Inc.Lundbeck Company Details
11.4.2 Ceregene Inc.Lundbeck Business Overview
11.4.3 Ceregene Inc.Lundbeck Huntingtons Disease Therapeutics Introduction
11.4.4 Ceregene Inc.Lundbeck Revenue in Huntingtons Disease Therapeutics Business (2020-2025)
11.4.5 Ceregene Inc.Lundbeck Recent Development
11.5 Prana Biotechnology Limited
11.5.1 Prana Biotechnology Limited Company Details
11.5.2 Prana Biotechnology Limited Business Overview
11.5.3 Prana Biotechnology Limited Huntingtons Disease Therapeutics Introduction
11.5.4 Prana Biotechnology Limited Revenue in Huntingtons Disease Therapeutics Business (2020-2025)
11.5.5 Prana Biotechnology Limited Recent Development
11.6 Teva Pharmaceutical Industries Ltd.
11.6.1 Teva Pharmaceutical Industries Ltd. Company Details
11.6.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.6.3 Teva Pharmaceutical Industries Ltd. Huntingtons Disease Therapeutics Introduction
11.6.4 Teva Pharmaceutical Industries Ltd. Revenue in Huntingtons Disease Therapeutics Business (2020-2025)
11.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.7 Cortex Pharmaceuticals lnc.
11.7.1 Cortex Pharmaceuticals lnc. Company Details
11.7.2 Cortex Pharmaceuticals lnc. Business Overview
11.7.3 Cortex Pharmaceuticals lnc. Huntingtons Disease Therapeutics Introduction
11.7.4 Cortex Pharmaceuticals lnc. Revenue in Huntingtons Disease Therapeutics Business (2020-2025)
11.7.5 Cortex Pharmaceuticals lnc. Recent Development
11.8 VertexPharmaceuticals Incorporated
11.8.1 VertexPharmaceuticals Incorporated Company Details
11.8.2 VertexPharmaceuticals Incorporated Business Overview
11.8.3 VertexPharmaceuticals Incorporated Huntingtons Disease Therapeutics Introduction
11.8.4 VertexPharmaceuticals Incorporated Revenue in Huntingtons Disease Therapeutics Business (2020-2025)
11.8.5 VertexPharmaceuticals Incorporated Recent Development
11.9 Auspex Pharmaceuticals
11.9.1 Auspex Pharmaceuticals Company Details
11.9.2 Auspex Pharmaceuticals Business Overview
11.9.3 Auspex Pharmaceuticals Huntingtons Disease Therapeutics Introduction
11.9.4 Auspex Pharmaceuticals Revenue in Huntingtons Disease Therapeutics Business (2020-2025)
11.9.5 Auspex Pharmaceuticals Recent Development
11.10 SOM Biotech
11.10.1 SOM Biotech Company Details
11.10.2 SOM Biotech Business Overview
11.10.3 SOM Biotech Huntingtons Disease Therapeutics Introduction
11.10.4 SOM Biotech Revenue in Huntingtons Disease Therapeutics Business (2020-2025)
11.10.5 SOM Biotech Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Huntingtons Disease Therapeutics Introduction
11.11.4 GlaxoSmithKline Revenue in Huntingtons Disease Therapeutics Business (2020-2025)
11.11.5 GlaxoSmithKline Recent Development
11.12 Siena Biotech
11.12.1 Siena Biotech Company Details
11.12.2 Siena Biotech Business Overview
11.12.3 Siena Biotech Huntingtons Disease Therapeutics Introduction
11.12.4 Siena Biotech Revenue in Huntingtons Disease Therapeutics Business (2020-2025)
11.12.5 Siena Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
AmpliPhi Biosciences Corp
Prana Biotechnology Limited
Teva Pharmaceutical Industries Ltd
Auspex Pharmaceuticals
SOM Biotech
GlaxoSmithKline PLC
ValeantPharmaceuticals International lnc.
Ceregene Inc.Lundbeck
Cortex Pharmaceuticals lnc.
VertexPharmaceuticals Incorporated
Siena Biotech
List of Tables
 Table 1. Global Huntingtons Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Psychotherapy
 Table 3. Key Players of Medical Treatement
 Table 4. Key Players of Others
 Table 5. Global Huntingtons Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Huntingtons Disease Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Huntingtons Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Huntingtons Disease Therapeutics Market Share by Region (2020-2025)
 Table 9. Global Huntingtons Disease Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Huntingtons Disease Therapeutics Market Share by Region (2026-2031)
 Table 11. Huntingtons Disease Therapeutics Market Trends
 Table 12. Huntingtons Disease Therapeutics Market Drivers
 Table 13. Huntingtons Disease Therapeutics Market Challenges
 Table 14. Huntingtons Disease Therapeutics Market Restraints
 Table 15. Global Huntingtons Disease Therapeutics Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Huntingtons Disease Therapeutics Market Share by Players (2020-2025)
 Table 17. Global Top Huntingtons Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Huntingtons Disease Therapeutics as of 2024)
 Table 18. Ranking of Global Top Huntingtons Disease Therapeutics Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Huntingtons Disease Therapeutics Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Huntingtons Disease Therapeutics, Headquarters and Area Served
 Table 21. Global Key Players of Huntingtons Disease Therapeutics, Product and Application
 Table 22. Global Key Players of Huntingtons Disease Therapeutics, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Huntingtons Disease Therapeutics Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Huntingtons Disease Therapeutics Revenue Market Share by Type (2020-2025)
 Table 26. Global Huntingtons Disease Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Huntingtons Disease Therapeutics Revenue Market Share by Type (2026-2031)
 Table 28. Global Huntingtons Disease Therapeutics Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Huntingtons Disease Therapeutics Revenue Market Share by Application (2020-2025)
 Table 30. Global Huntingtons Disease Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Huntingtons Disease Therapeutics Revenue Market Share by Application (2026-2031)
 Table 32. North America Huntingtons Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Huntingtons Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Huntingtons Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Huntingtons Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Huntingtons Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Huntingtons Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Huntingtons Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Huntingtons Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Huntingtons Disease Therapeutics Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Huntingtons Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Huntingtons Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Huntingtons Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Huntingtons Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Huntingtons Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Huntingtons Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 47. ValeantPharmaceuticals International lnc. Company Details
 Table 48. ValeantPharmaceuticals International lnc. Business Overview
 Table 49. ValeantPharmaceuticals International lnc. Huntingtons Disease Therapeutics Product
 Table 50. ValeantPharmaceuticals International lnc. Revenue in Huntingtons Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 51. ValeantPharmaceuticals International lnc. Recent Development
 Table 52. Alnylam Pharmaceuticals Inc. Company Details
 Table 53. Alnylam Pharmaceuticals Inc. Business Overview
 Table 54. Alnylam Pharmaceuticals Inc. Huntingtons Disease Therapeutics Product
 Table 55. Alnylam Pharmaceuticals Inc. Revenue in Huntingtons Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 56. Alnylam Pharmaceuticals Inc. Recent Development
 Table 57. AmpliPhi Biosciences Corp Company Details
 Table 58. AmpliPhi Biosciences Corp Business Overview
 Table 59. AmpliPhi Biosciences Corp Huntingtons Disease Therapeutics Product
 Table 60. AmpliPhi Biosciences Corp Revenue in Huntingtons Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 61. AmpliPhi Biosciences Corp Recent Development
 Table 62. Ceregene Inc.Lundbeck Company Details
 Table 63. Ceregene Inc.Lundbeck Business Overview
 Table 64. Ceregene Inc.Lundbeck Huntingtons Disease Therapeutics Product
 Table 65. Ceregene Inc.Lundbeck Revenue in Huntingtons Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 66. Ceregene Inc.Lundbeck Recent Development
 Table 67. Prana Biotechnology Limited Company Details
 Table 68. Prana Biotechnology Limited Business Overview
 Table 69. Prana Biotechnology Limited Huntingtons Disease Therapeutics Product
 Table 70. Prana Biotechnology Limited Revenue in Huntingtons Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 71. Prana Biotechnology Limited Recent Development
 Table 72. Teva Pharmaceutical Industries Ltd. Company Details
 Table 73. Teva Pharmaceutical Industries Ltd. Business Overview
 Table 74. Teva Pharmaceutical Industries Ltd. Huntingtons Disease Therapeutics Product
 Table 75. Teva Pharmaceutical Industries Ltd. Revenue in Huntingtons Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 76. Teva Pharmaceutical Industries Ltd. Recent Development
 Table 77. Cortex Pharmaceuticals lnc. Company Details
 Table 78. Cortex Pharmaceuticals lnc. Business Overview
 Table 79. Cortex Pharmaceuticals lnc. Huntingtons Disease Therapeutics Product
 Table 80. Cortex Pharmaceuticals lnc. Revenue in Huntingtons Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 81. Cortex Pharmaceuticals lnc. Recent Development
 Table 82. VertexPharmaceuticals Incorporated Company Details
 Table 83. VertexPharmaceuticals Incorporated Business Overview
 Table 84. VertexPharmaceuticals Incorporated Huntingtons Disease Therapeutics Product
 Table 85. VertexPharmaceuticals Incorporated Revenue in Huntingtons Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 86. VertexPharmaceuticals Incorporated Recent Development
 Table 87. Auspex Pharmaceuticals Company Details
 Table 88. Auspex Pharmaceuticals Business Overview
 Table 89. Auspex Pharmaceuticals Huntingtons Disease Therapeutics Product
 Table 90. Auspex Pharmaceuticals Revenue in Huntingtons Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 91. Auspex Pharmaceuticals Recent Development
 Table 92. SOM Biotech Company Details
 Table 93. SOM Biotech Business Overview
 Table 94. SOM Biotech Huntingtons Disease Therapeutics Product
 Table 95. SOM Biotech Revenue in Huntingtons Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 96. SOM Biotech Recent Development
 Table 97. GlaxoSmithKline Company Details
 Table 98. GlaxoSmithKline Business Overview
 Table 99. GlaxoSmithKline Huntingtons Disease Therapeutics Product
 Table 100. GlaxoSmithKline Revenue in Huntingtons Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 101. GlaxoSmithKline Recent Development
 Table 102. Siena Biotech Company Details
 Table 103. Siena Biotech Business Overview
 Table 104. Siena Biotech Huntingtons Disease Therapeutics Product
 Table 105. Siena Biotech Revenue in Huntingtons Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 106. Siena Biotech Recent Development
 Table 107. Research Programs/Design for This Report
 Table 108. Key Data Information from Secondary Sources
 Table 109. Key Data Information from Primary Sources
 Table 110. Authors List of This Report


List of Figures
 Figure 1. Huntingtons Disease Therapeutics Picture
 Figure 2. Global Huntingtons Disease Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Huntingtons Disease Therapeutics Market Share by Type: 2024 VS 2031
 Figure 4. Psychotherapy Features
 Figure 5. Medical Treatement Features
 Figure 6. Others Features
 Figure 7. Global Huntingtons Disease Therapeutics Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Huntingtons Disease Therapeutics Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Case Studies
 Figure 10. Clinic Case Studies
 Figure 11. Others Case Studies
 Figure 12. Huntingtons Disease Therapeutics Report Years Considered
 Figure 13. Global Huntingtons Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Huntingtons Disease Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Huntingtons Disease Therapeutics Market Share by Region: 2024 VS 2031
 Figure 16. Global Huntingtons Disease Therapeutics Market Share by Players in 2024
 Figure 17. Global Top Huntingtons Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Huntingtons Disease Therapeutics as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Huntingtons Disease Therapeutics Revenue in 2024
 Figure 19. North America Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Huntingtons Disease Therapeutics Market Share by Country (2020-2031)
 Figure 21. United States Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Huntingtons Disease Therapeutics Market Share by Country (2020-2031)
 Figure 25. Germany Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Huntingtons Disease Therapeutics Market Share by Region (2020-2031)
 Figure 33. China Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Huntingtons Disease Therapeutics Market Share by Country (2020-2031)
 Figure 41. Mexico Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Huntingtons Disease Therapeutics Market Share by Country (2020-2031)
 Figure 45. Turkey Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Huntingtons Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. ValeantPharmaceuticals International lnc. Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2020-2025)
 Figure 49. Alnylam Pharmaceuticals Inc. Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2020-2025)
 Figure 50. AmpliPhi Biosciences Corp Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2020-2025)
 Figure 51. Ceregene Inc.Lundbeck Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2020-2025)
 Figure 52. Prana Biotechnology Limited Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2020-2025)
 Figure 53. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2020-2025)
 Figure 54. Cortex Pharmaceuticals lnc. Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2020-2025)
 Figure 55. VertexPharmaceuticals Incorporated Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2020-2025)
 Figure 56. Auspex Pharmaceuticals Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2020-2025)
 Figure 57. SOM Biotech Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2020-2025)
 Figure 58. GlaxoSmithKline Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2020-2025)
 Figure 59. Siena Biotech Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Targeted Drugs for Huntington s Disease Market Research Report 2024
Global Huntington Disease Protein Market Research Report 2024
Neurodegenerative Diseases Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neurodegenerative Disorder Therapeutics Market Research Report 2024
Mitochondrial Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rare Disease Therapeutic Market Research Report 2024
Global Neurodegenerative Disease Treatment Market Research Report 2024
Celiac Disease Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Neurodegenerative Diseases Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Protein Therapeutics Market
Syndromes Progressive Ataxia Weakness Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Retinal Degenerative Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Retinal Degenerative Disease Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Huntington Disease Medications Market Research Report 2024
Moderate To Severe Acne Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Neurodegenerative Disease Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Spinal Muscular Atrophy SMA Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neuroregeneration Therapy Market Research Report 2024
Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Therapy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions